(129) included 120 systemic lupus erythematosus (SLE) patients and found that serum anti-C1Q antibody and urinary ceruloplasmin levels were associated with CCL2 activity in chronic injury. The gene discussed is CCL2; the disease is systemic lupus erythematosus.